The tumour uptake of [18F]-FLT was monitored over 1 hour at baseline and on day 2 of treatment with the PI3K inhibitor GDC-0941 and the MEK inhibitor PD 0325901, alone and in combination. This evidence concerns the gene MAP2K7 and neoplasm.